Australia’s National Health Systems (NHS) provides universal, tax-financed coverage to all citizens. To control the cost of medicines, NHS created a Pharmaceutical Benefits Advisory Committee (PBAC) to advise whether and, if so, how government should subsidize drugs. A central feature of PBAC is cost-effectiveness research. With U.S. policymakers searching for ways to rein in Medicare and Medicaid drug spending, the Australian experience assumes special relevance.

Sorting Out Sense from Nonsense on Global Warming

You are invited to attend a special documentary filming session of “An Inconvenient Truth…Or Convenient Fiction” with Dr. Steven Hayward, senior fellow at the Pacific Research Institute, F.K. Weyerhaeuser Fellow at the American Enterprise Institute, and author of the annual Index of Leading Environmental Indicators.